Works matching IS 10837159 AND DT 2020 AND VI 25 AND IP 2
Results: 37
The Clinical Impact of Cancer Stem Cells.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 123, doi. 10.1634/theoncologist.2019-0517
- By:
- Publication type:
- Article
Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 156, doi. 10.1634/theoncologist.2019-0542
- By:
- Publication type:
- Article
Mortality of Pregnancy Following Breast Cancer Diagnoses in Taiwanese Women.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e252, doi. 10.1634/theoncologist.2019-0451
- By:
- Publication type:
- Article
Bioelectrical Impedance Analysis for the Assessment of Sarcopenia in Patients with Cancer: A Systematic Review.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 170, doi. 10.1634/theoncologist.2019-0600
- By:
- Publication type:
- Article
Impact of Baseline Nutrition and Exercise Status on Toxicity and Outcomes in Phase I and II Oncology Clinical Trial Participants.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 161, doi. 10.1634/theoncologist.2019-0289
- By:
- Publication type:
- Article
Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials with Time‐to‐Event Outcomes.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 91, doi. 10.1634/theoncologist.2019-0464
- By:
- Publication type:
- Article
Real‐World Toxicity Experience with BRAF/MEK Inhibitors in Patients with Erdheim‐Chester Disease.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e386, doi. 10.1634/theoncologist.2019-0606
- By:
- Publication type:
- Article
Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e391, doi. 10.1634/theoncologist.2019-0467
- By:
- Publication type:
- Article
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 140, doi. 10.1634/theoncologist.2019-0508
- By:
- Publication type:
- Article
Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 94, doi. 10.1634/theoncologist.2019-0636
- By:
- Publication type:
- Article
ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer—A Retrospective Analysis.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e284, doi. 10.1634/theoncologist.2019-0510
- By:
- Publication type:
- Article
Association of Age with Efficacy of Immunotherapy in Metastatic Melanoma.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e381, doi. 10.1634/theoncologist.2019-0377
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e396, doi. 10.1634/theoncologist.2019-0515
- By:
- Publication type:
- Article
Validity and Reliability of the Memorial Delirium Assessment Scale‐Thai Version (MDAS‐T) for Assessment of Delirium in Palliative Care Patients.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e335, doi. 10.1634/theoncologist.2019-0399
- By:
- Publication type:
- Article
FDA Approval Summary: Ruxolitinib for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e328, doi. 10.1634/theoncologist.2019-0627
- By:
- Publication type:
- Article
Survivorship Care Plans in Cancer: A Meta‐Analysis and Systematic Review of Care Plan Outcomes.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e351, doi. 10.1634/theoncologist.2019-0184
- By:
- Publication type:
- Article
Health‐Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor‐Positive, HER2‐Negative Advanced Breast Cancer After Endocrine Therapy.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e243, doi. 10.1634/theoncologist.2019-0551
- By:
- Publication type:
- Article
A Nationwide, Multicenter Registry Study of Antiemesis for Carboplatin‐Based Chemotherapy‐Induced Nausea and Vomiting in Japan.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e373, doi. 10.1634/theoncologist.2019-0292
- By:
- Publication type:
- Article
De Novo Versus Recurrent HER2‐Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e214, doi. 10.1634/theoncologist.2019-0446
- By:
- Publication type:
- Article
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2‐Year Durable Response.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e198, doi. 10.1634/theoncologist.2019-0603
- By:
- Publication type:
- Article
Lenvatinib in Management of Solid Tumors.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e302, doi. 10.1634/theoncologist.2019-0407
- By:
- Publication type:
- Article
Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e231, doi. 10.1634/theoncologist.2019-0427
- By:
- Publication type:
- Article
Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor‐Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care‐BC): A Randomized Controlled Phase III Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e223, doi. 10.1634/theoncologist.2019-0382
- By:
- Publication type:
- Article
Urine Drug Testing in Cancer Pain Management.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 99, doi. 10.1634/theoncologist.2019-0525
- By:
- Publication type:
- Article
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 112, doi. 10.1634/theoncologist.2019-0356
- By:
- Publication type:
- Article
Surgery Versus Surveillance for Well‐Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11‐Year Analysis of the National Cancer Database.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e276, doi. 10.1634/theoncologist.2019-0466
- By:
- Publication type:
- Article
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e311, doi. 10.1634/theoncologist.2019-0309
- By:
- Publication type:
- Article
Prevalence of NRAS Mutation, PD‐L1 Expression and Amplification, and Overall Survival Analysis in 36 Primary Vaginal Melanomas.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e291, doi. 10.1634/theoncologist.2019-0148
- By:
- Publication type:
- Article
Feasibility of Treating Adults with Ewing or Ewing‐Like Sarcoma with Interval‐Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 150, doi. 10.1634/theoncologist.2019-0532
- By:
- Publication type:
- Article
Withholding the Introduction of Anti‐Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild‐Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study).
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e266, doi. 10.1634/theoncologist.2019-0328
- By:
- Publication type:
- Article
The European Medicines Agency Review of Kymriah (Tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukemia and Diffuse Large B‐Cell Lymphoma.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e321, doi. 10.1634/theoncologist.2019-0233
- By:
- Publication type:
- Article
Implementation of Best Practice Recommendations for Palliative Care in German Comprehensive Cancer Centers.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e259, doi. 10.1634/theoncologist.2019-0126
- By:
- Publication type:
- Article
Workup and Management of Immune‐Mediated Hepatobiliary Pancreatic Toxicities That Develop During Immune Checkpoint Inhibitor Treatment.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 105, doi. 10.1634/theoncologist.2018-0162
- By:
- Publication type:
- Article
A Phase II Study of Perioperative Capecitabine plus Oxaliplatin Therapy for Clinical SS/SE N1‐3 M0 Gastric Cancer (OGSG 1601).
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 119, doi. 10.1634/theoncologist.2019-0601
- By:
- Publication type:
- Article
Prevention of Venous Thromboembolism in Pancreatic Cancer: Breaking Down a Complex Clinical Dilemma.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 132, doi. 10.1634/theoncologist.2019-0264
- By:
- Publication type:
- Article
A Phase I Study of Alpha‐1,3‐Galactosyltransferase‐Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 121, doi. 10.1634/theoncologist.2019-0599
- By:
- Publication type:
- Article
Lifetime Transfusion Burden and Transfusion‐Related Iron Overload in Adult Survivors of Solid Malignancies.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e341, doi. 10.1634/theoncologist.2019-0222
- By:
- Publication type:
- Article